Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

Prostate cancer is the second most common cancer in men worldwide and causes over 250,000 deaths each year(1). Overtreatment of indolent disease also results in significant morbidity(2). Common genetic alterations in prostate cancer include losses of NKX3.1 (8p21)(3,4) and PTEN (10q23)(5,6), gains o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Barbieri, Christopher E., Baca, Sylvan C., Lawrence, Michael S., Demichelis, Francesca, Blattner, Mirjam, Theurillat, Jean-Philippe, White, Thomas A., Stojanov, Petar, Van Allen, Eliezer, Stransky, Nicolas, Nickerson, Elizabeth, Chae, Sung-Suk, Boysen, Gunther, Auclair, Daniel, Onofrio, Robert, Park, Kyung, Kitabayashi, Naoki, MacDonald, Theresa Y., Sheikh, Karen, Vuong, Terry, Guiducci, Candace, Cibulskis, Kristian, Sivachenko, Andrey, Carter, Scott L., Saksena, Gordon, Voet, Douglas, Hussain, Wasay M., Ramos, Alex H., Winckler, Wendy, Redman, Michelle C., Ardlie, Kristin, Tewari, Ashutosh K., Mosquera, Juan Miguel, Rupp, Niels, Wild, Peter J., Moch, Holger, Morrissey, Colm, Nelson, Peter S., Kantoff, Philip W., Gabriel, Stacey B., Golub, Todd R., Meyerson, Matthew, Lander, Eric S., Getz, Gad, Rubin, Mark A., Garraway, Levi A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3673022/
https://ncbi.nlm.nih.gov/pubmed/22610119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ng.2279
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak